Co-Authors
This is a "connection" page, showing publications co-authored by Francesca Ponziani and Maurizio Pompili.
Connection Strength
9.227
-
NAFLD or comorbidities, that is the question. J Hepatol. 2020 09; 73(3):723.
Score: 0.878
-
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Ther Adv Med Oncol. 2019; 11:1758835919848184.
Score: 0.822
-
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018 12; 48(11-12):1301-1311.
Score: 0.792
-
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018 Jul; 12(7):641-656.
Score: 0.771
-
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma. World J Hepatol. 2017 Dec 28; 9(36):1322-1331.
Score: 0.748
-
Diagnostic and prognostic role of circulating microparticles in hepatocellular carcinoma. J Hepatol. 2017 Sep 21.
Score: 0.734
-
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban. Liver Int. 2017 08; 37(8):1251.
Score: 0.710
-
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. Am J Kidney Dis. 2017 Aug; 70(2):297-300.
Score: 0.706
-
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients. Dig Liver Dis. 2021 05; 53(5):541-544.
Score: 0.233
-
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection. Gastroenterology. 2021 04; 160(5):1891-1893.
Score: 0.230
-
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13072-13088.
Score: 0.229
-
Letter: liver involvement and mortality in COVID-19 patients - authors' reply. Aliment Pharmacol Ther. 2020 Oct; 52(7):1264-1265.
Score: 0.226
-
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther. 2020 09; 52(6):1060-1068.
Score: 0.224
-
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study. Sci Rep. 2019 10 25; 9(1):15373.
Score: 0.212
-
Low molecular weight heparin as cause of liver injury: case report and literature review. Eur Rev Med Pharmacol Sci. 2019 Sep; 23(17):7649-7654.
Score: 0.210
-
Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report. Infection. 2019 Apr; 47(2):313-316.
Score: 0.198
-
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
Score: 0.194
-
Treatment of early stage chronic hepatitis C virus infection. Expert Rev Clin Pharmacol. 2018 May; 11(5):519-524.
Score: 0.190
-
Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time? Dig Dis Sci. 2017 09; 62(9):2220-2222.
Score: 0.183
-
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol. 2017 Jul 07; 23(25):4491-4499.
Score: 0.181
-
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol. 2017 Mar 08; 9(7):352-367.
Score: 0.177
-
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):23-36.
Score: 0.177
-
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (= 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. Eur Rev Med Pharmacol Sci. 2019 Sep; 23(18):7786-7801.
Score: 0.053
-
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? Eur J Radiol. 2019 May; 114:32-37.
Score: 0.051
-
Bile Collection Detected With BrIDA Scintigraphy in a Patient With Hepatocellular Carcinoma. Clin Nucl Med. 2018 Nov; 43(11):823-824.
Score: 0.050
-
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. J Viral Hepat. 2018 12; 25(12):1493-1500.
Score: 0.049